Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Phase 3 Thyroid Eye Disease (TED) Trials

2 Phase 3 trials for Thyroid Eye Disease (TED). Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.

What is a Phase 3 trial?

Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
RECRUITINGPhase 3NCT07262476

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 2581 location
RECRUITINGPhase 3NCT07257185

MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

The primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered Q4W for 6 months, in...

Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 1501 location